15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-ß hydrolysis.
University Of Lille
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1 modifications for the exploration of the S1 subsite.
Glaxosmithkline
Phage-encoded combinatorial chemical libraries based on bicyclic peptides.
Laboratory Of Molecular Biology, Medical Research Council
Thiol-based angiotensin-converting enzyme 2 inhibitors: P1' modifications for the exploration of the S1' subsite.
Glaxosmithkline
Enzyme inhibition as a potential therapeutic strategy to treat COVID-19 infection.
Kingston University
Discovery of honokiol thioethers containing 1,3,4-oxadiazole moieties as potential ?-glucosidase and SARS-CoV-2 entry inhibitors.
Zhengzhou University
Synthetic Peptides That Antagonize the Angiotensin-Converting Enzyme-2 (ACE-2) Interaction with SARS-CoV-2 Receptor Binding Spike Protein.
University Of Groningen
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens.
University Of California San Francisco (Ucsf)
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-?-lactamases.
Qpex Biopharma
The Other Angiotensin II Receptor: AT
Centre Hospitalier Universitaire Vaudois (Chuv) And University Of Lausanne (Unil
Design of SARS-CoV-2 PLpro Inhibitors for COVID-19 Antiviral Therapy Leveraging Binding Cooperativity.
University Of Illinois At Chicago
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
University Of Bonn
Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors.
Millennium Pharmaceuticals